Nebenwirkungen · Braftovi
Braftovi 50 mg hard capsules Braftovi 75 mg hard capsules · Abschnitt 4.8 · PDF-Seite 14
HOS-140077 · Präparat HOS-098444
Basal cell Basal cell carcinoma* New Primary Uncommo Basal cell carcinoma* Melanoma* n carcinoma Blood and lymphatic system disorders Very Anaemia Neutropenia* common Anaemia* Thrombocytopenia * Leukopenia* Immune system disorders Very Hypersensitivityb common Common Hypersensitivityb Hypersensitivityb Hypersensitivityb Metabolism and nutrition disorders Very Decreased Decreased appetite Decreased appetite common appetite Hypokalaemia Hypomagnesaemia Hypoalbuminaemi a* Not Tumour lysis known syndrome Psychiatric disorders Very Insomnia Insomnia Insomnia* common Nervous system disorders Headache* Neuropathy Neuropathy peripheral* Neuropathy Neuropathy peripheral* Headache* peripheraln Very peripheral* Dizziness* Dysgeusia* common Dysgeusia* Headache* Headache*
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-01T15:53:00Z · SHA-256 47125c84bb304df39202c4dc14aefc287bbf903ef279d3e55fe42dc6648e375c · Passage 71323380c3d8f64c4f992d56f52d3c46fec52042c2e010c999925319cca9432f · Zeichen 5284–7371 im Abschnitt